糖尿病性骨质疏松症中医药治疗进展
|
摘要
糖尿病是一种长期慢性代谢性疾病,随着人口老龄化和人们生活方式的改变,糖尿病发病率逐年上升。糖尿病性骨质疏松症(DOP)是糖尿病常见的慢性并发症之一,其发病率、致残率高,严重影响患者的生活质量,日益受到医学界的重视。近年来,关于糖尿病合并骨质疏松症的中医认识和治疗逐渐深入,并且在临床实践中取得明显疗效,文章就近年来糖尿病性骨质疏松症的中医治疗作相关综述,以期更好地指导临床。
Diabetes is a long-term chronic metabolic disease. With the aging of the population and changes in people's lifestyles, the incidence of diabetes is increasing year by year. Diabetic Osteoporosis(DOP) is one of the common chronic complications of diabetes. Its incidence and disability rate are high, which seriously affects the quality of life of patients. It is increasingly valued by the medical community. In recent years, the understanding and treatment of diabetes mellitus complicated with osteoporosis has gradually deepened and achieved remarkable curative effect in clinical practice. This article reviews recent Chinese medicine treatment of diabetic osteoporosis in order to better guide the clinical.
Diabetes is a long-term chronic metabolic disease. With the aging of the population and changes in people's lifestyles, the incidence of diabetes is increasing year by year. Diabetic Osteoporosis(DOP) is one of the common chronic complications of diabetes. Its incidence and disability rate are high, which seriously affects the quality of life of patients. It is increasingly valued by the medical community. In recent years, the understanding and treatment of diabetes mellitus complicated with osteoporosis has gradually deepened and achieved remarkable curative effect in clinical practice. This article reviews recent Chinese medicine treatment of diabetic osteoporosis in order to better guide the clinical.
引文
[1]中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中国实用内科杂志,2018,38(2):127-150.
[2]Azuma K.Therapeutic considerations on secondary osteoporosis caused by diabetes mellitus[J].Clin Calcium,2009,19(9):1345-1352.
[3]王寒啸.糖尿病并发骨质疏松发病机制的探究[J].中国医药指南,2018,16(21):19-20.
[4]安艳军,曹天一,牟新.糖尿病合并骨质疏松症研究现状[J].新中医,2018,50(10):22-25.
[5]李文昌,蒋四兵,刘勇,等.中西医结合与西医治疗老年骨质疏松症的临床对比[J].昆明医科大学学报,2016,37(2):80-82.
[6]李富震,姜德友,白玉宾,等.基于古今文献试论中医药治疗糖尿病骨质疏松症的思路[J].辽宁中医志,2015,42(1):50-51.
[7]朱丽华,张贤.糖尿病骨质疏松中医病机探析[J].中国中医骨伤科杂志,2011,19(2):57-58.
[8]马如风,郭鱼波,王丽丽,等.糖尿病性骨质疏松的中医病因病机分析和临床研究进展[J].中华中医药学刊,2016,34(8):1803-1806.
[9]刘菊,梅群超,张林英,等.补肾活血方对老年2型糖尿病合并骨质疏松症患者骨代谢标志物、骨密度的影响[J].中医学报,2018,33(07):1226-1229.
[10]黄菊,舒仪琼.温阳滋阴固肾法治疗糖尿病性骨质疏松症的研究进展[J].湖南中医杂志,2015,31(6):176-178.
[11]陶乐维.糖尿病性骨质疏松症中医研究现状[J].四川中医,2013,31(2):129-131.
[12]李环宇,张林.从“虚”“瘀”防治糖尿病骨质疏松症的方药研究探讨[J].时珍国医国药,2015,26(2):417-418.
[13]苏友新,郭进建,郑良朴,等.糖尿病性骨质疏松症的中医证候研究[J].福建中医学院学报,2002(1):26-29.
[14]曲震,曾伟坤,庞瑞明,等.糖尿病性骨质疏松症中医证候特点及体质分布的临床研究[J].中医临床研究,2018,10(11):96-97.
[15]杨利芳.观察复方地龙片联合阿法骨化醇软胶丸、碳酸钙咀嚼片治疗糖尿病合并骨质疏松的疗效[J].中西医结合心血管病电子杂志,2018,6(30):178.)
[16]张贤梅,孙勤国,江波,等.糖松康合剂对糖尿病性骨质疏松大鼠的治疗作用及其对IGF-1和GLP-1表达的影响[J].中国中医骨伤科杂志,2018,26(9):5-8.
[17]辛瑞文,祝健红,杨文龙,等.骨疏宁片联合阿托伐他汀对2型糖尿病合并绝经后骨质疏松症患者骨密度及骨代谢的影响[J].中国骨质疏松杂志,2018,24(8):1060-1063.
[18]李蔓.补肾活血汤治疗糖尿病骨质疏松症的疗效分析[J].中西医结合心血管病电子杂志,2018,6(20):145.
[19]杨龙.补肾活血汤治疗糖尿病骨质疏松症疗效观察[J].糖尿病新世界,2016,19(7):50-51.
[20]刘海亭.益肾壮骨合剂联合钙尔奇D治疗糖尿病合并骨质疏松症的临床分析[J].糖尿病新世界,2018,21(14):88-89.
[21]张杰文,谢政权,林靖,等.季兵从肾虚血瘀论治糖尿病骨质疏松经验[J].湖南中医杂志,2018,34(5):41-42.
[22]季兵,关健华,陈先明,等.补肾活血方治疗2型糖尿病骨质疏松的临床观察[J].中国医药指南,2012,10(17):3-4.
[23]楚淑芳,赵恒侠,刘德亮,等.糖尿病性骨质疏松的中医药防治[J].世界中医药,2018,13(7):1804-1808+1812.
[24]郭丰年,倪青.从脏腑气机失调看消渴病病机[J].环球中医药,2018,11(6):861-862.
[2]Azuma K.Therapeutic considerations on secondary osteoporosis caused by diabetes mellitus[J].Clin Calcium,2009,19(9):1345-1352.
[3]王寒啸.糖尿病并发骨质疏松发病机制的探究[J].中国医药指南,2018,16(21):19-20.
[4]安艳军,曹天一,牟新.糖尿病合并骨质疏松症研究现状[J].新中医,2018,50(10):22-25.
[5]李文昌,蒋四兵,刘勇,等.中西医结合与西医治疗老年骨质疏松症的临床对比[J].昆明医科大学学报,2016,37(2):80-82.
[6]李富震,姜德友,白玉宾,等.基于古今文献试论中医药治疗糖尿病骨质疏松症的思路[J].辽宁中医志,2015,42(1):50-51.
[7]朱丽华,张贤.糖尿病骨质疏松中医病机探析[J].中国中医骨伤科杂志,2011,19(2):57-58.
[8]马如风,郭鱼波,王丽丽,等.糖尿病性骨质疏松的中医病因病机分析和临床研究进展[J].中华中医药学刊,2016,34(8):1803-1806.
[9]刘菊,梅群超,张林英,等.补肾活血方对老年2型糖尿病合并骨质疏松症患者骨代谢标志物、骨密度的影响[J].中医学报,2018,33(07):1226-1229.
[10]黄菊,舒仪琼.温阳滋阴固肾法治疗糖尿病性骨质疏松症的研究进展[J].湖南中医杂志,2015,31(6):176-178.
[11]陶乐维.糖尿病性骨质疏松症中医研究现状[J].四川中医,2013,31(2):129-131.
[12]李环宇,张林.从“虚”“瘀”防治糖尿病骨质疏松症的方药研究探讨[J].时珍国医国药,2015,26(2):417-418.
[13]苏友新,郭进建,郑良朴,等.糖尿病性骨质疏松症的中医证候研究[J].福建中医学院学报,2002(1):26-29.
[14]曲震,曾伟坤,庞瑞明,等.糖尿病性骨质疏松症中医证候特点及体质分布的临床研究[J].中医临床研究,2018,10(11):96-97.
[15]杨利芳.观察复方地龙片联合阿法骨化醇软胶丸、碳酸钙咀嚼片治疗糖尿病合并骨质疏松的疗效[J].中西医结合心血管病电子杂志,2018,6(30):178.)
[16]张贤梅,孙勤国,江波,等.糖松康合剂对糖尿病性骨质疏松大鼠的治疗作用及其对IGF-1和GLP-1表达的影响[J].中国中医骨伤科杂志,2018,26(9):5-8.
[17]辛瑞文,祝健红,杨文龙,等.骨疏宁片联合阿托伐他汀对2型糖尿病合并绝经后骨质疏松症患者骨密度及骨代谢的影响[J].中国骨质疏松杂志,2018,24(8):1060-1063.
[18]李蔓.补肾活血汤治疗糖尿病骨质疏松症的疗效分析[J].中西医结合心血管病电子杂志,2018,6(20):145.
[19]杨龙.补肾活血汤治疗糖尿病骨质疏松症疗效观察[J].糖尿病新世界,2016,19(7):50-51.
[20]刘海亭.益肾壮骨合剂联合钙尔奇D治疗糖尿病合并骨质疏松症的临床分析[J].糖尿病新世界,2018,21(14):88-89.
[21]张杰文,谢政权,林靖,等.季兵从肾虚血瘀论治糖尿病骨质疏松经验[J].湖南中医杂志,2018,34(5):41-42.
[22]季兵,关健华,陈先明,等.补肾活血方治疗2型糖尿病骨质疏松的临床观察[J].中国医药指南,2012,10(17):3-4.
[23]楚淑芳,赵恒侠,刘德亮,等.糖尿病性骨质疏松的中医药防治[J].世界中医药,2018,13(7):1804-1808+1812.
[24]郭丰年,倪青.从脏腑气机失调看消渴病病机[J].环球中医药,2018,11(6):861-862.